EBITDA of USD 134.7m (-11% vs. ARCe, -20% vs. Cons.)DPS of USD 0.40/sh (12.8% running yield); -33% vs. Cons.Q4 bookings suggest EBITDA of USD ~155m (Cons.: USD ~200m)Soft report, but valuation support mitigates downside.... P/NAV of 0.79x and Q4 will be better
